DK2264060T3 - Sammensætninger og fremgangsmåder til inhibering af viral adhæsion - Google Patents

Sammensætninger og fremgangsmåder til inhibering af viral adhæsion

Info

Publication number
DK2264060T3
DK2264060T3 DK10189277.6T DK10189277T DK2264060T3 DK 2264060 T3 DK2264060 T3 DK 2264060T3 DK 10189277 T DK10189277 T DK 10189277T DK 2264060 T3 DK2264060 T3 DK 2264060T3
Authority
DK
Denmark
Prior art keywords
compositions
methods
inhibiting viral
viral adhesion
adhesion
Prior art date
Application number
DK10189277.6T
Other languages
English (en)
Inventor
Jan Holgersson
Original Assignee
Recopharma Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recopharma Ab filed Critical Recopharma Ab
Application granted granted Critical
Publication of DK2264060T3 publication Critical patent/DK2264060T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4727—Mucins, e.g. human intestinal mucin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2796/00—Viruses not covered by groups C12N2710/00 - C12N2795/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK10189277.6T 2006-01-26 2007-01-26 Sammensætninger og fremgangsmåder til inhibering af viral adhæsion DK2264060T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76279606P 2006-01-26 2006-01-26
EP07804693A EP1973941A2 (en) 2006-01-26 2007-01-26 Compositions and methods for inhibiting viral adhesion

Publications (1)

Publication Number Publication Date
DK2264060T3 true DK2264060T3 (da) 2014-07-28

Family

ID=38653386

Family Applications (1)

Application Number Title Priority Date Filing Date
DK10189277.6T DK2264060T3 (da) 2006-01-26 2007-01-26 Sammensætninger og fremgangsmåder til inhibering af viral adhæsion

Country Status (9)

Country Link
US (3) US20070184065A1 (da)
EP (4) EP2264060B1 (da)
JP (3) JP5199886B2 (da)
AU (1) AU2007251256B2 (da)
CA (1) CA2635011A1 (da)
DK (1) DK2264060T3 (da)
ES (1) ES2502966T3 (da)
PT (1) PT2264060E (da)
WO (1) WO2007132355A2 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20100111275A (ko) * 2008-01-03 2010-10-14 메사츄세츠 인스티튜트 어브 테크놀로지 유인 인플루엔자 치료제
WO2010010948A1 (ja) * 2008-07-25 2010-01-28 国立大学法人 群馬大学 血液型関連物質を用いたノロウイルスの感染防御又は除去
US20150051139A1 (en) * 2012-02-06 2015-02-19 Massachusetts Institute Of Technology Mucins as Antiviral Compounds
WO2013162771A1 (en) 2012-04-23 2013-10-31 Massachusetts Institute Of Technology Lectin conjugates for mucin hydration
WO2016130498A1 (en) 2015-02-10 2016-08-18 Massachusetts Institute Of Technology Isolated mucins and different microoorganisms, and methods of use
JP7084627B2 (ja) * 2018-06-06 2022-06-15 株式会社マナＨｓコーポレーション ウイルス感染症予防用組成物

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US4485045A (en) * 1981-07-06 1984-11-27 Research Corporation Synthetic phosphatidyl cholines useful in forming liposomes
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US4544545A (en) 1983-06-20 1985-10-01 Trustees University Of Massachusetts Liposomes containing modified cholesterol for organ targeting
US4710761A (en) 1985-07-09 1987-12-01 American Telephone And Telegraph Company, At&T Bell Laboratories Window border generation in a bitmapped graphics workstation
US5225538A (en) 1989-02-23 1993-07-06 Genentech, Inc. Lymphocyte homing receptor/immunoglobulin fusion proteins
US5328470A (en) 1989-03-31 1994-07-12 The Regents Of The University Of Michigan Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
US5013556A (en) 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
US6136310A (en) * 1991-07-25 2000-10-24 Idec Pharmaceuticals Corporation Recombinant anti-CD4 antibodies for human therapy
US5516964A (en) 1994-01-21 1996-05-14 Sun Company, Inc. (R&M) Hydrocarbon isomerization using solid superacid catalysts comprising platinum metal
US5705364A (en) * 1995-06-06 1998-01-06 Genentech, Inc. Mammalian cell culture process
SE9701127D0 (sv) * 1997-03-26 1997-03-26 Karolinska Innovations Ab Antigenic fusionprotein carrying GALal, 3GAL epitopes
CA2412701A1 (en) * 2000-06-28 2002-01-03 Glycofi, Inc. Methods for producing modified glycoproteins
CA2454469A1 (en) * 2001-07-20 2003-02-06 Absorber, Ab Blood group antigen fusion polypeptides and methods of use thereof
EP1517923A2 (en) * 2002-04-22 2005-03-30 Recopharma AB Compositions and methods for inhibiting microbial adhesion
WO2003088995A2 (en) * 2002-04-22 2003-10-30 Recopharma Ab Mucin fusion polypeptide vaccines, compositions and methods of use thereof
US20040001844A1 (en) * 2002-04-22 2004-01-01 Jan Holgersson Lewis Y epitope-containing mucin fusion polypeptide vaccines, compositions and methods of use thereof
US7638323B2 (en) * 2002-08-09 2009-12-29 Recopharma Ab Fusion proteins and methods of producing same
CA2589422A1 (en) * 2004-10-14 2007-04-12 Recopharma Ab Compositions and methods for inhibiting h. pylori adhesion and infection

Also Published As

Publication number Publication date
EP2264060B1 (en) 2014-04-23
WO2007132355A2 (en) 2007-11-22
PT2264060E (pt) 2014-07-28
JP5199886B2 (ja) 2013-05-15
JP2012214522A (ja) 2012-11-08
US20120020969A1 (en) 2012-01-26
CA2635011A1 (en) 2007-11-22
US20070184065A1 (en) 2007-08-09
EP2264061A1 (en) 2010-12-22
WO2007132355A3 (en) 2008-04-24
JP2013064016A (ja) 2013-04-11
ES2502966T3 (es) 2014-10-06
EP2264060A1 (en) 2010-12-22
EP1973941A2 (en) 2008-10-01
JP2009528270A (ja) 2009-08-06
AU2007251256B2 (en) 2013-03-07
AU2007251256A1 (en) 2007-11-22
EP2781524A1 (en) 2014-09-24
US20140256019A1 (en) 2014-09-11

Similar Documents

Publication Publication Date Title
DK2087002T3 (da) Sammensætninger og fremgangsmåder til binding af sphingosin-1-phosphat
DK2203478T3 (da) Sammensætninger og fremgangsmåder til anvendelse af antistoffer mod sclerostin
DK2001611T3 (da) Fremgangsmåde og sammensætning til oprensning af jord
HRP20160410T8 (hr) Inhibitori hepatitis c virusa
DK2066339T3 (da) Sammensætninger og fremgangsmåder til forstærkning af immunreaktioner
DK3207941T3 (da) Fremgangsmåder og sammensætninger på basis af diphtheritoksin-interleukin-3-konjugater
DK2565193T3 (da) Sammensætninger og fremgangsmåder til hæmning af JAK-signalvejen
DK2029746T3 (da) Sammensætninger og fremgangsmåder til siRNA-hæmning af angiogenese
DK3156069T3 (da) Sammensætninger, fremgangsmåder, og kits til fremkaldelse af et immunrespons
DK2570467T3 (da) Sammensætninger af tetrafluorpropen og carbonhydrider
DK2470656T3 (da) Sammensætning til hæmning af genekspression og anvendelser heraf
DK2253644T3 (da) Sammensætninger og fremgangsmåder til fremstilling af en sammensætning
DK2046264T3 (da) Fremgangsmåder til fremstillingen af sammensætninger med film
DK1737461T3 (da) Carbolin-derivater til inhibering af angiogenese
DK2099489T3 (da) Sammensætninger og fremgangsmåder til behandling af en neoplasme
DK3263589T5 (da) Peptidsekvenser og sammensætninger
DK2137537T3 (da) Sammensætninger og anvendelser til behandling af multipel sklerose
DK2041071T3 (da) Biarylsammensætninger og fremgangsmåder til modulering af en kinasekaskade
DK3263112T3 (da) Sammensætninger og fremgangsmåder til undertrykkelse af endometriproliferationer
SI2094702T1 (sl) Virusni inhibitorji
DK1912476T3 (da) Fremgangsmåde til træning af høreevne
DK1986508T3 (da) Fremgangsmåder og sammensætninger til behandling af felin hyperthyroidisme
DK2320739T3 (da) Farmaceutiske sammensætninger og fremgangsmåder til stabilisering af disse
DK2264060T3 (da) Sammensætninger og fremgangsmåder til inhibering af viral adhæsion
DK2262525T3 (da) Apoaequorin-holdige sammensætninger og fremgangsmåder til anvendelse af de samme